Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer

Justin Jee, Emily S. Lebow, Randy Yeh, +69

Nature Medicine

Tumor Dna-guided TherapyOverall SurvivalMedicineBronchial NeoplasmCancer Treatment +5

ATRX loss is an independent predictor of poor survival in pancreatic neuroendocrine tumors

Angela Chou, Malinda Itchins, Philip R. de Reuver, +11

Human Pathology

Pancreatic CancerPoor SurvivalMedicineIndependent PredictorNeuroendocrine Disorder +7

Relationship between PD-L1 expression and outcome in EGFR-mutant lung cancer patients treated with EGFR tyrosine kinase inhibitors

Jia Liu, Malinda Itchins, Adnan Nagrial, +16

Lung Cancer

OncologyPd-l1 ExpressionMedicinePathologyBronchial Neoplasm +5

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Oliver Illini, Maximilian J. Hochmair, Hannah Fabikan, +30

Therapeutic Advances in Medical Oncology

A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer

Marliese Alexander, Nick Pavlakis, Thomas John, +11

Lung Cancer

Thromboembolic EventsMedicineCancer ManagementPathologyBronchial Neoplasm +6

The Prognostic and Predictive Role of the Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Lymphocyte-to-Monocyte Ratio (LMR) as Biomarkers in Resected Pancreatic Cancer

Sarah Maloney, Nick Pavlakis, Malinda Itchins, +10

Journal of Clinical Medicine

EGFR Exon 20 Insertion Mutations: Clinicopathological Characteristics and Treatment Outcomes in Advanced Non–Small Cell Lung Cancer

José Luis Leal, Marliese Alexander, Malinda Itchins, +9

Clinical Lung Cancer

Insertion MutationsMedicinePathologyCancer GenomicsEgfr Exon 20 +7

Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy

Sumit Sahni, Christopher B. Nahm, Christoph Krisp, +11

Frontiers in Oncology

Retrospective cohort analysis of neoadjuvant treatment and survival in resectable and borderline resectable pancreatic ductal adenocarcinoma in a high volume referral centre

Malinda Itchins, Jennifer Arena, Christopher B. Nahm, +15

European Journal of Surgical Oncology

Surgical OncologyPancreatic CancerGastrointestinal OncologyMedicineNeoadjuvant Treatment +5

Brief Report: Real-World Toxicity and Survival of Combination Immunotherapy in Pleural Mesothelioma—RIOMeso

Nicholas McNamee, Catriona Harvey, Lauren Gray, +19

Journal of Thoracic Oncology

Real-world ToxicityMedicineBrief ReportImmunologyPathology +4